Literature DB >> 15596624

Dopamine agonists modify the course of Parkinson disease.

Matthew B Stern1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15596624     DOI： 10.1001/archneur.61.12.1969

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  3 in total

1.  Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.

Authors:  G Gille; K Radad; H Reichmann; W-D Rausch
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 2.  Levodopa alone compared with levodopa-sparing therapy as initial treatment for Parkinson's disease: a meta-analysis.

Authors:  Cheng-long Xie; Yun-Yun Zhang; Xiao-Dan Wang; Jie Chen; Yi-He Chen; Jia-Lin Pa; Shi-Yi Lin; Hua-Zhen Lin; Wen-Wen Wang
Journal:  Neurol Sci       Date:  2015-05-17       Impact factor: 3.307

3.  Current approaches to the treatment of Parkinson's disease.

Authors:  Joseph Jankovic; L Giselle Aguilar
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.